To conclude, we propose that a combination of standard peripheral blood biomarkers of acute inflammatory response, cell death and hypercoagulability, i.e., CRP, LDH and fibrinogen, reflects the severity of COVID-19 per se independently of comorbidities, age and sex, being of value for risk stratification in unselected patients. This evidence concerns the gene CRP and thrombophilia.